Penn Medicine Researchers Present Advance in Re-Treatment with CAR T Therapy
Perelman School of Medicine at the University of PennsylvaniaResearchers from the University of Pennsylvania’s Abramson Cancer Center presented preliminary results of an ongoing Phase I clinical trial demonstrating successful re-treatment with CAR T cell therapy for patients whose cancers relapsed after previous CAR T therapy at the 2022 American Society of Hematology (ASH) Annual Meeting (Abstract 2016).